OSTOMY MEDICAL DEVICE WITH WORLDWIDE SALES

by | Oct 22, 2025 | Active, Manufacturing, Manufacturing, Med-Tech

OSTOMY MEDICAL DEVICE WITH WORLDWIDE SALES

 
NVC2265
 

About the Company

This ostomy medical device provides comfort, ease and peace of mind to thousands of patients across the U.S. and overseas. The long-established brand name is instantly recognizable to those who need and use the device and to those medical professionals who recommend it. A Midwest-based Company manufactures and markets the trademarked and copyrighted product, which has been registered with the U.S. Food and Drug Administration since before its original introduction to the market more than 25 years ago. With its strong brand and loyal customers, the device represents a growth opportunity for a medical supply company with the resources to expand on its record of success.  

GROWTH OPPORTUNITIES

Revamped manufacturing – Taking production in-house would likely reduce the cost of bringing the product to market. 

Emphasizing sales – For major manufacturers in this space, there is a significant opportunity to increase penetration with existing channels. 

International business – While current sales are primarily in the U.S., there are established international customers that can be expanded with significant growth potential. 

INVESTMENT HIGHLIGHTS 

Established brand – The product enjoys wide name recognition among medical professionals and patients for the ease and peace of mind it brings to users. 

Adaptability – It can be easily used in conjunction with other manufacturer’s medical devices. 

Lack of competition – There is no legitimate direct competitor.  

Supplier relationships – After decades of successful sales, the product is a known commodity with nearly two dozen medical supply companies.  

MARKET OPPORTUNITY

Our device is used with an essential complementary device 

North America –  

  • Complementary device sales: 82,000,000 units annually
  • Target market share: 20%
  • Estimated units: 16,400,000
  • Total potential revenue: $16,400,000 

International – 

  • There is a significant opportunity for sales in Japan, South Korea, Australia and New Zealand as well as additional sales in Europe.
  • Combined, complementary devices sales are estimated at over 100,000,000 units annually.    

REVENUE AND EBITDA

2024 Revenue: $480,000 

2024 EBITDA: $250,000 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

MIDWEST MEDICAL DEVICE MANUFACTURING COMPANY

by | Oct 15, 2025 | Active, Manufacturing, Manufacturing, Med-Tech

Midwest Medical Device Manufacturing Company

 
NVC2265
 

About the Company

This Midwest Medical Device Manufacturing Company specializes in ultrasonic wound therapy systems and medical devices. The focus is on medical and surgical instruments, particularly for wound care, with additional product lines pending FDA clearance. Based in the Midwest with global reach, the company generates significant revenue with a low number of employees. Primary services include the design and manufacture of ultrasonic wound therapy systems and the development of medical devices for wound care. Key capabilities include expertise in ultrasonic technology for medical applications, ongoing research and development for new product lines, and compliance with regulatory standards. 

GROWTH OPPORTUNITIES

Expansion into New Markets – There is significant potential to expand into emerging markets where the prevalence of chronic wounds is increasing in regions with aging populations. 

Technological Innovations – Continued investment in research and development can lead to the creation of more advanced and effective wound care solutions.  

INVESTMENT HIGHLIGHTS 

Growing Market Demand – The global market for wound care devices is expanding, driven by the increasing prevalence of chronic wounds and the aging population.  

Market Focus – The Company’s device is primarily used for treating chronic and complex wounds, such as diabetic ulcers, pressure sores, venous ulcers, burn treatments and surgical wounds. 

Value Focused – The Company’s mission and values focus on patient solutions, improving quality care by fostering technology and creativity to anticipate emerging needs. 

REVENUE AND EBITDA

  2023 Actual  2024 Actual  2025 Forecast 
Revenue  $1,450,000  $11,340,000  $14,740,000 
EBITDA  -$170,000  $3,500,000  $4,700,000 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

MECHANICAL CONSTRUCTION AND INDUSTRIAL MRO COMPANY

by | Oct 14, 2025 | Active, Manufacturing, Manufacturing

MECHANICAL CONSTRUCTION AND INDUSTRIAL MRO COMPANY

RA220

About the Company

A well-established, full-service industrial and mechanical construction and MRO firm based in the Midwest with over 40 years of proven success. The Company delivers end-to-end solutions, including: 

  • Specialized Industrial Services – piping, rigging, millwright services, structural steel, insulation, scaffolding, and HVAC. 
  • Construction & Project Execution – spanning concept, engineering support, execution, and completion. 
  • Facility Maintenance & Operational Support – “nested” plant maintenance teams and long-term facility support agreements.  

Serving customers in the chemical, food and beverage, renewable energy, consumer goods, steel, air separation, pulp and paper, pharmaceuticals, plastics, and oil and gas end markets, the Company is driven by a seasoned leadership team and a strong operational culture. Its scalable platform benefits from a solid reputation, long-standing client relationships, and consistent performance. The Company offers attractive growth opportunities for strategic or financial buyers. 

GROWTH OPPORTUNITIES

Current Opportunities: 

  • Projected revenue of approximately $165,000,000 for the 2025 fiscal year, more than doubling since 2022. 
  • Projected backlog of $100,000,000+ secured for 2026, supporting visibility and growth. 
  • A strong focus on higher-margin projects across diverse industries. 

Strategic Initiatives: 

  • Investment in business development resources to further expand into the Southeastern U.S. 
  • Implementation of an enhanced ERP platform in order to improve project controls and efficiency. 
  • Pursuing expanded service offerings, including increased data center construction capabilities, growth in modular fabrication services, and additional long-term facility maintenance agreements. 
INVESTMENT HIGHLIGHTS 
Long-Term Excellence:  Four decades of industry leadership with a proven track record. Highly skilled team of talented, committed construction and maintenance professionals. 

Advantageous Contract Structures – Approximately 50% of 2024 and 2025 revenue has come from cost-reimbursable / NTE structures, mitigating cost overrun and project delay risks. 

Safety First – As the #1 core value, the Company’s safety culture is embedded at every organizational level, which drives client confidence and reduces operational risk. 

Maintenance & Facility Support – Approximately 15% of annual revenue comes from “nested employee” maintenance & operational agreements, enhancing client “stickiness” and providing recurring revenue. 

REVENUE AND EBITDA

  2023  2024  TTM 
Revenue  $85,000,000 $130,000,000 $170,000,000
EBITDA  $5,000,000 $8,000,000 $17,000,000

 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

U.S. ORTHOPEDIC DEVICE DEVELOPER AND SELLER

by | Oct 13, 2025 | Active, Manufacturing, Med-Tech

U.S. ORTHOPEDIC DEVICE DEVELOPER AND SELLER

NVC2270

About the Company

ExoToe, a U.S.-based Company, developed, obtained federal clearance, commercialized and sells an implant device for surgical use throughout the U.S. The product has been clinically tested, safe and effective alternative to existing surgical interventions. The implant received FDA clearance just before the COVID pandemic, which slowed the Company’s momentum. The device was developed by Drs. Jordan Grossman, Michael Lee, and Shannon Rush, three of the most well-known and respected opinion leaders in foot and ankle surgery. The objective has always been to de-risk the implant for a future owner and not grow the Company. With its evidence-based technology and safe track record, the Company presents a growth opportunity for a new owner.

GROWTH OPPORTUNITIES

  • Increased sales emphasis – The goal was to de-risk, show efficacy and sell to an orthopedic company, not to grow into a standalone business. There is a limited sales team and business is generated through word of mouth or write-ups in medical journals presenting a significant opportunity for growth for a new owner. 
  • Repeat business – The implant has an impressive track record, but little effort has been made to build relationships with surgeons who have successfully employed it. 
  • Scalable Manufacturing – The current manufacturer of record possesses all necessary ISO certifications and offers the scalability required to meet market demands. 
  • Platform Technology – The implant’s current application is for toes but could easily be adapted to hand and other upper extremities. 
INVESTMENT HIGHLIGHTS 
  • Intellectual property – The Company has valuable intellectual property for crimping of fixation for foot bone fractures and fusions. 
  • High success rate – The device has been in the market long enough to show that it works, is safe and effective minimizing risk for a new owner. An independent publication in a peer-review journal demonstrated a best in class fusion rates. 
  • Patient, surgeon satisfaction – The implant’s success rate and ease of use have won over many doctors and patients. 
  • Another option – The implants provide an alternative to other types of devices which have had mixed success.  It is also the revisional implant of choice when primary procedures fail. 
  • Partners in place – The Company has established relationships with capable outside vendors for manufacturing and logistics. It also has a complete DHF (Design History File) and QMS (Quality Management System). 
  • Additional complementary device – The Company is in the process of FDA clearance for a complementary device in the same space creating an additional opportunity for new owners to generate revenue. 
  • Cumulative Devices Implanted – Well over 2,000 

 

REVENUE AND EBITDA

Market Opportunity  Sales Team Projection 
Total annual implant revisions: 30,000 Total sales reps: 200 
Target market share: 30%  Sales per rep per week: 1 unit 
Estimated units: 9,000  Selling weeks per year: 50 (assuming 2 weeks off) 
Revenue per unit: $1,000–$1,200  Total units sold: 200 reps × 1 unit/week × 50 weeks = 10,000 units 
Total potential revenue: $9M–$11M  Projected revenue: $10M–$12M 

 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

MIDWEST MANUFACTURING SOFTWARE DEVELOPER

by | Sep 29, 2025 | Active, Manufacturing, Service

Midwest Manufacturing Software Developer

 
NVC2253 

About the Company

This fast-growing Midwest software developer provides manufacturers with customizable systems that gather automated production data, integrate it with other business systems, and make it accessible and meaningful at the plant floor, management level, database and beyond. Its connectivity software simplifies and streamlines manufacturers’ production monitoring, recipe management, quality/statistical process control and work instructions. The software allows clients to maximize efficiency and profitability and more accurately determine return on investment. The Company has developed loyal customers across a broad geographical area in the U.S. and internationally and presents a strong growth opportunity for a new owner. 

GROWTH OPPORTUNITIES

Rising sales – Sales have grown substantially over the past three years, with another good year forecasted for 2024. 

Enhanced marketing – Current sales are primarily through word of mouth and marketing is practically nonexistent. The Company’s website is also overdue for a refresh. An increased focus on sales and marketing could boost revenues. 

Product development – The Company continues to improve and add features to its software products, oftentimes at the request of customers. 

INVESTMENT HIGHLIGHTS 

Customization – The Company understands customers’ unique needs and customizes software to fit them. 

Talented staff – Employees have the programming skills and product knowledge to please even the most demanding customers. 

Widespread sales – Sales are spread geographically, with about 40% in Michigan, 40% elsewhere in the U.S. and 20% international. 

REVENUE AND EBITDA

  2021  2022  2023  2024 Pipeline 
Revenue  $440,000 $1,000,000 $1,800,000 $2,500,000
EBITDA  -$80,000 $200,000 $700,000  

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

BUYSIDE: PLASTIC INJECTION MOLD MAKER

by | Sep 17, 2025 | Active, Buy-Side, Manufacturing

BUY-SIDE:

PLASTIC INJECTION MOLD MAKER 

NVC2272

 

This Buyer is a well-established, US-based Plastic Injection Molding Company. They have built a strong reputation over the decades by serving a diverse and impressive client base, including major Fortune 500 companies in the hospitality, custodial, food service, and automotive industries.  They have a comprehensive in-house design and engineering with state-of-the-art CAD and 3D prototyping to full-scale manufacturing and fulfillment.  They have been operated by the current management for 20 years This Buyer’s business offers numerous services and products including in-house tool maintenance, pre-assembly, welding/bonding, insert molding as well as ISO 9001:2015 certification.

STRATEGIC FIT FACTORS: WHAT WE’RE LOOKING FOR 

  • Plastic Injection Molding Businesses 
  • Less than 35% Automotive focused work 
  • Companies with revenue between $5M-$20M 
  • Ideally located within the Great Lakes Region 
  • Presses with 500 lb. or more ability 

MOTIVATION: WHY WE’RE LOOKING FOR AN ACQUISITION

The Buyer’s business is expanding beyond what their current facility can handle and because of their track record of problem solving and reliability, their clients are asking them to take on more work. They are looking for a business with current capacity and hopefully the ability to expand their operations. 

 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106